Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report

Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report

Since December 2019, the outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly around the world. The severity of COVID-19 ranges from asymptomatic carriers to severe acute respiratory distress syndrome (ARDS). Accumulating evidence has shown that COVID-19 may be associated with multiple...

Full description

Bibliographic Details
Main Authors: Hao-Yu Wu, Chien-Ting Pan, Chiao-Feng Cheng, Chi-Ying Lin, Sheng-Nan Chang, Yi-Chung Chen, Chih-Yuan Wang, Yen-Fu Chen, Chung-Yu Chen, Matthew Huei-Ming Ma, Juey-Jen Hwang
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Journal of the Formosan Medical Association
Subjects:
COVID-19
ARDS
IVIg
Baricitinib
Creatine kinase
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664621001194

Internet

http://www.sciencedirect.com/science/article/pii/S0929664621001194

Similar Items